NEW ENGLAND CONSORTIUM NODE

NEW ENGLAND CONSORTIUM NODE

Principal Investigators:
Gail D'Onofrio, MD, MS [email]
Yale University School of Medicine
Chair, Department of Emergency Medicine
464 Congress Avenue
Suite 260
New Haven, CT 06519

Roger D. Weiss, MD [email]
Department of Psychiatry
Harvard Medical School
Division of Alcohol and Drug Abuse
McLean Hospital
115 Mill St.
Belmont, MA 02478-9106

Node Newsletter

(2011-2015)
NIDA web site

The New England Consortium Node was established in 2010, combining into a single node both the Regional Research and Training Centers and the Community Treatment Programs of the original New England and Northern New England nodes.

It includes programs in Massachusetts, Connecticut, Maine, and Rhode Island.

RRTCs: McLean Hospital and VA Connecticut Healthcare Center

NEW ENGLAND CONSORTIUM NODE PROTOCOL INVOLVEMENT

CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules
CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0005 MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults
CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
CTN-0016 Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings
CTN-0017 HIV and HCV Intervention in Drug Treatment Settings
CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment
CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment
CTN-0020 Job Seekers Training for Patients with Drug Dependence
CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse
CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)
CTN-0027-A-1 START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
CTN-0027-A-2 Retention of Suboxone Patients in START: Perspectives of Providers and Patients
CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)
CTN-0029 A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD
CTN-0030 Prescription Opioid Addiction Treatment Study (POATS)
CTN-0030-A-1 Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
CTN-0030-A-2 Effects of Chronic Opioids on the Brain
CTN-0030-A-3 Protocol Amendment to Examine Long-Term Outcomes
CTN-0032 HIV Rapid Testing and Counseling
CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
CTN-0047 Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
CTN-0050 Long Term Follow-Up of START Patients
CTN-0051

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
CTN-0051-A-1 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study
CTN-0051-A-2 Treatment-As-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with CTN-0051
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care among HIV/HCV Co-infected Substance Users
CTN-0080 Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs) (NIH HEAL Initiative)
CTN-0081 Emergency Medicine Opioid Data Infrastructure: Key Venue to Address Opioid Morbidity and Mortality (Project CODE PRO --Capturing Opioid Use Disorder Electronically and Patient Reported Outcomes)
CTN-0092 OUD Phenotyping Feasibility for Clinical Trials (NIH HEAL Initiative)
CTN-0096 Culturally Centered MAT for OUD Implementation Facilitation for Primary Care and Addiction Treatment Programs Serving American Indian/Alaska Natives (NIH HEAL Initiative)
CTN-0099 Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION) (NIH HEAL Initiative)
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 5/2019 -- http://ctndisseminationlibrary.org/nodes/necnode.htm
info@ctndisseminationlibrary.org